Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Array Biopharma IncfiledCriticalArray Biopharma Inc
Priority claimed from PCT/US2003/035670external-prioritypatent/WO2004046101A2/en
Publication of MXPA05005370ApublicationCriticalpatent/MXPA05005370A/en
Cyanoguanidine quinazoline and cyanoamidine quinazolamine derivatives that are useful in the treatment of hyperproliferative diseases are disclosed. Use of the compounds of the invention to manufacture therapeutic compositions for the treatment of hyperproliferative diseases in mammals is also disclosed.
MXPA05005370A2002-11-202003-11-10Cyanoguanidines and cyanoamidines as erbb2 and egfr inhibitors.
MXPA05005370A
(en)